Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4012
Gene Symbol: LNPEP
LNPEP
0.310 Biomarker phenotype CTD_human A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. 11730987 2001
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype BEFREE A significant component of memory loss in APP transgenic mice is apparently caused by soluble A Beta assemblies, but whether and how much of the dementia within individuals afflicted with AD is caused by these A Beta species is unclear. 11773429 2002
Entrez Id: 84867
Gene Symbol: PTPN5
PTPN5
0.010 Biomarker phenotype BEFREE Accumulating evidence over the past decade indicates that STEP dysregulation contributes to the pathophysiology of several neuropsychiatric disorders, including Alzheimer's disease, schizophrenia, fragile X syndrome, epileptogenesis, alcohol-induced memory loss, Huntington's disease, drug abuse, stroke/ischemia, and inflammatory pain. 22090472 2012
Entrez Id: 56848
Gene Symbol: SPHK2
SPHK2
0.300 Biomarker phenotype CTD_human Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. 24859201 2014
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. 18191838 2008
Entrez Id: 1139
Gene Symbol: CHRNA7
CHRNA7
0.300 Therapeutic phenotype CTD_human Alpha7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice. 18848931 2009
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE Alzheimer's disease (AD) is a neurodegenerative disorder characterized by loss of memory and cognitive abilities, and the appearance of amyloid plaques composed of the amyloid-β peptide (Aβ) and neurofibrillary tangles formed of tau protein. 25763997 2016
Entrez Id: 551
Gene Symbol: AVP
AVP
0.300 Therapeutic phenotype CTD_human Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. 11553362 2001
Entrez Id: 5663
Gene Symbol: PSEN1
PSEN1
0.350 GeneticVariation phenotype BEFREE An increased amount or mutation(s) in PS1, which alters the stoichiometric balance of the gamma-secretase complex, may be the cause of aberrant or increased processing of APP, resulting in Abeta accumulation leading to loss of memory. 19181896 2009
Entrez Id: 351
Gene Symbol: APP
APP
0.400 GeneticVariation phenotype BEFREE An increased amount or mutation(s) in PS1, which alters the stoichiometric balance of the gamma-secretase complex, may be the cause of aberrant or increased processing of APP, resulting in Abeta accumulation leading to loss of memory. 19181896 2009
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.010 AlteredExpression phenotype BEFREE As the effects of VP2.51 were concomitant with the increase in β-catenin expression and a shift towards the inactive form of GSK-3, we suggest that VP2.51 has therapeutic benefits following stress, and it may be a preventive treatment in situations where a potential depressive state and/or loss of memory is associated with diminished neurogenesis, through selective GSK3-beta inhibition. 28012947 2017
Entrez Id: 2521
Gene Symbol: FUS
FUS
0.020 Biomarker phenotype BEFREE At the molecular level, we demonstrated that mitochondria of Fus1 KO cells have low reserve respiratory capacity (the ability to produce extra energy during sudden energy demanding situations), and show significantly altered dynamics of cellular calcium response.Our recent studies on early hearing and memory loss in Fus1 KO mice combined with the new data presented here suggest that calcium and energy homeostasis controlled by Fus1 may be at the core of its aging-regulating activities. 28351997 2017
Entrez Id: 11334
Gene Symbol: TUSC2
TUSC2
0.010 Biomarker phenotype BEFREE At the molecular level, we demonstrated that mitochondria of Fus1 KO cells have low reserve respiratory capacity (the ability to produce extra energy during sudden energy demanding situations), and show significantly altered dynamics of cellular calcium response.Our recent studies on early hearing and memory loss in Fus1 KO mice combined with the new data presented here suggest that calcium and energy homeostasis controlled by Fus1 may be at the core of its aging-regulating activities. 28351997 2017
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. 20816828 2010
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype BEFREE Autophagy impairment by caspase-1-dependent inflammation mediates memory loss in response to β-Amyloid peptide accumulation. 28801921 2018
Entrez Id: 10280
Gene Symbol: SIGMAR1
SIGMAR1
0.300 Therapeutic phenotype CTD_human Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine. 15451042 2005
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. 29860433 2018
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. 15364477 2004
Entrez Id: 2571
Gene Symbol: GAD1
GAD1
0.010 Biomarker phenotype BEFREE Blocking hippocampal GAD or GABA<sub>A</sub> receptors in ovx animals reproduced recognition memory loss similar to PCP and inhibited estradiol's protection of recognition memory in PCP-treated animals. 29529524 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE Brain aging and Alzheimer's disease both demonstrate the accumulation of beta-amyloid protein containing "plaques" and tau protein containing "tangles" that contribute to accelerated memory loss and cognitive decline. 30728442 2019
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD
0.010 AlteredExpression phenotype BEFREE By analyzing the correlations between these brain regions and behavioral data, we observed a close correlation between decreased HIPP/ParaHIPP activity and memory loss; increased PCC activity and strength of FC with the AUG.L were related to dysfunction of executive function and attention network in patients with UC. 31001097 2019
Entrez Id: 5966
Gene Symbol: REL
REL
0.300 Biomarker phenotype CTD_human Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. 20477932 2010
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.100 Biomarker phenotype BEFREE Decreased brain-derived neurotrophic factor (BDNF) contributes to memory loss in Alzheimer's disease (AD), and soluble assemblies of amyloid-beta (Aβ) and tau contribute to neurodegeneration. 26410307 2015
Entrez Id: 112935892
Gene Symbol: LINC02605
LINC02605
0.010 Biomarker phenotype BEFREE Depletion results from both direct infection and bystander loss of memory CD4<sup>+</sup> T cells in part attributed to dysregulated IL-7/IL-7R signaling. 31507594 2019
Entrez Id: 3574
Gene Symbol: IL7
IL7
0.010 Biomarker phenotype BEFREE Depletion results from both direct infection and bystander loss of memory CD4<sup>+</sup> T cells in part attributed to dysregulated IL-7/IL-7R signaling. 31507594 2019